MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
104 hedge funds and large institutions have $411M invested in Marinus Pharmaceuticals, Inc in 2023 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 30 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $485M → $411M (-$73.9M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
104
Holding in Top 10
2
Calls
$12.3M
Puts
$1.53M
Top Buyers
| 1 | +$21.1M | |
| 2 | +$19.9M | |
| 3 | +$10.9M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$9.24M |
| 5 |
Jennison Associates
New York
|
+$8.77M |
Top Sellers
| 1 | -$5.7M | |
| 2 | -$4.24M | |
| 3 | -$3.1M | |
| 4 |
D.E. Shaw & Co
New York
|
-$2.76M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.09M |